|
|
The pubmed stuff seems to be mainly abstracts as far as I can access. But here is a line from one of them which seems to be mentioned in on form or another in most.
The pathogenesis of Parkinson's disease (PD) remains obscure, but there is increasing evidence that impairment of mitochondrial function, oxidative damage, and inflammation are contributing factors.
"Contibuting factor" are the words that I want to focus on here. You're not wrong that mitochondrial dysfunction is one of the causative agents of these conditions (and thanks for the links, it's always nice to learn something new). However, it is inaccurate to say that it is at the heart of the condition. There are other factors which contribute to the development of these diseases.
One factor is that of genetics. It has been established that there are inheritable genetic factors which make one more likely to develop these conditions.
Earlier you asked how this particular technique could be used to study Alzheimers as it is a condition which generally presents later in life.
From the wiki on Somatic cell nuclear transfer technology:
A potential use of genetically-customized stem cells would be to create cell lines that have any genes linked to a particular disease. For example, if a person with Parkinson's disease donated his or her somatic cells, then the stem cells resulting SCNT would have any genes which contribute to Parkinson's disease. In this scenario, the disease-specific stem cell lines would be studied in order to better understand the disease.
This abstract was taken from Pubmed by following the link sited by that sentance.
Human embryonic stem cells: origin, properties and applications.
Semb H.
Stem Cell Center, Lund University, Lund, Sweden. henrik.semb@med.lu.se
Human embryonic stem cells originate from the human preimplantation embryo. The derivation of the first human embryonic stem cells was reported in 1998. Since then we have learnt a great deal about how to isolate and culture these cells. Additionally, their stem cell phenotype and differentiation competence have been determined. Although it is expected that many basic biological properties, such as self-renewal and cell specification, are evolutionary conserved, at least from the mouse, we lack significant knowledge about the molecular events that regulate the unique stem cell features of human embryonic stem cells. The pluripotent nature of human embryonic stem cells has attracted great interest in using them as a source of cells and tissues in cell therapy. Recent progress in human somatic cell nuclear transfer suggests that there may be a solution to the immunotolerance problems associated with the use of human embryonic stem cells in cell-replacement therapy. Thus, human embryonic stem cells supply the research community with unique research tools to study basic biological processes in human cells, model human genetic diseases and develop new cell-replacement therapies.
In this particular branch of Alzheimer's research the origin of the mitochondria in the cells is irrelevant, because that isn't what is being investigated here.
I understand your concerns regarding the legal and ethical questions surrounding the concept of creating human/animal chimeras even at a purely cellular level. But I think that as long as we are vigilant and ensure that we don't try to, for instance, use this as the foothold to breed a race of "lab humans" for testing purposes then this is an acceptable level of development. |
|
|